Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(30 sites)

United States

Mayo Clinic Arizona, Phoenix, Arizona

USC Norris comprehensive cancer center, Los Angeles, California

Stanford University Medical Centre, Palo Alto, California

UCSF, San Francisco, California

UCLA, Santa Monica, California